Previous 10 | Next 10 |
SuRo Capital Corp. (SSSS) is expected to report for quarter end 2023-12-31 Enviva Inc. (EVA) is expected to report $-0.76 for Q4 2023 Jushi Holdings Inc. - Class B (Sub Voting) (JUSHF) is expected to report $-0.04 for Q4 2023 U Power Limited (UCAR) is expected to report for quarter en...
2024-03-08 08:30:06 ET Ainos ( AIMD ) +147% . Psyence Biomedical ( PBM ) +104% . CERo Therapeutics ( CERO ) +47% . Gulf Island Fabrication ( GIFI ) +27% on Q4 earnings release . Recruiter.com ( RCRT ) +17% . Porch Group ( P...
ASHBURN, Va., March 07, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, announced today that the Company plans to release its fourth qu...
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 86.2% to $0.0836 on volume of 666,955,822 shares Airship AI Holdings Inc (AISP) rose 200.0% to $4.95 on volume of 217,603,607 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.6% to $...
A look at the top 10 most actives in the United States Sunshine Biopharma Inc. (SBFM) rose 114.7% to $0.0964 on volume of 636,845,097 shares Airship AI Holdings Inc (AISP) rose 194.5% to $4.86 on volume of 190,976,862 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 9.0% to ...
2024-03-05 12:38:40 ET Gainers: Sunshine Biopharma ( SBFM ) +147% . Airship AI Holdings ( AISP ) +87% . Datasea ( DTSS ) +79% . Dave ( DAVE ) +58% . Apogee Therapeutics ( APGE ) +49% . Ocean Biomedical ( OCEA ) +50% ....
2024-03-05 11:33:18 ET More on Quoin Pharmaceuticals Quoin stock soars 60% on FDA update for ichthyosis drug Seeking Alpha’s Quant Rating on Quoin Pharmaceuticals Historical earnings data for Quoin Pharmaceuticals Financial information for Quoin Pharma...
2024-03-05 10:02:11 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Waters, Moderna most shorted ...
2024-03-05 08:31:33 ET Losers: Quoin Pharmaceuticals Ltd ( QNRX ) -43% announces pricing of $6.5 Million public offering. GigCapital5 ( QTI ) -43% . Gitlab GTLB -23% after Q4 earnings release . SEMrush Holdings SEMR -17% . after Q4 earnings re...
ASHBURN, Va., March 05, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a specialty pharmaceutical company focused on rare and orphan diseases, today announced the pricing of its "reasonable best efforts" public offering o...
News, Short Squeeze, Breakout and More Instantly...
Quoin Pharmaceuticals Ltd. Company Name:
QNRX Stock Symbol:
NASDAQ Market:
Quoin Pharmaceuticals Ltd. Website:
Clinical site to be Opened in Saudi Arabia Site Currently Treating Netherton Patients Who Are Eligible for Recruitment into Quoin Studies Experienced Local Clinical Research Organization Has Been Engaged Plans for the Opening of Additional International Sites at an Advan...
ASHBURN, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage specialty pharmaceutical company focused on rare and orphan diseases, today announces that it will be a Bronze Sponsor for the Foundat...
Agreement will focus on the development of novel topical rapamycin (sirolimus) formulations as potential treatments for a number of rare and orphan diseases UCC’s proprietary dissolvable microneedles technology and other approaches will be utilized to optimize the local delivery ...